nach oben

Intensive Care Medicine

Erschienen in:

28.04.2020 | COVID-19 | What's New in Intensive Care Zur Zeit gratis

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

verfasst von: Daniel E. Leisman, Clifford S. Deutschman, Matthieu Legrand

Erschienen in: Intensive Care Medicine | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

Current management guidelines for COVID-19 reflect the assumption that critically ill patients infected with SARS-CoV-2 develop acute respiratory distress syndrome (ARDS). However, emerging data and clinical reports increasingly suggest an alternative view that severe COVID-19 reflects a confluence of vascular dysfunction, thrombosis, and dysregulated inflammation. …

Nur mit Berechtigung zugänglich

Gattinoni L, Coppola S, Cressoni M, Busana M, Chiumello D (2020) Covid-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.202003-0817LE CrossRefPubMedPubMedCentral

Gattinoni L, Chiumello D, Caironi P et al (2020) COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med. https://doi.org/10.1007/s00134-020-06033-2 CrossRefPubMedPubMedCentral

Qin C, Zhou L, Hu Z et al (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa248 CrossRefPubMedPubMedCentral

Sinha P, Delucchi KL, McAuley DF, O’Kane CM, Matthay MA, Calfee CS (2020) Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med 8(3):247–257CrossRefPubMedPubMedCentral

Maude SL, Frey N, Shaw PA et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371(16):1507–1517CrossRefPubMedPubMedCentral

Caruso D, Zerunian M, Polici M et al (2020) Chest CT features of COVID-19 in Rome, Italy. Radiology. https://doi.org/10.1148/radiol.2020201237 CrossRefPubMed

Chen J, Wang X, Zhang S et al (2020) Findings of acute pulmonary embolism in COVID-19 patients (3/1/2020). SSRN

Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY (2020) Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2020.02.010 CrossRefPubMedPubMedCentral

Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMc2007575 CrossRefPubMedPubMedCentral

10.

Su H, Yang M, Wan C et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. https://doi.org/10.1016/j.kint.2020.04.003 CrossRefPubMedPubMedCentral

11.

Liu Z, Xiao X, Wei X et al (2020) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. https://doi.org/10.1002/jmv.25726 CrossRefPubMedPubMedCentral

12.

Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282:1–23CrossRefPubMedPubMedCentral

13.

Liu Y, Yang Y, Zhang C et al (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63(3):364–374CrossRefPubMedPubMedCentral

14.

Nukiwa T, Matsuoka R, Takagi H, Ishii Y, Arai T, Kira S (1982) Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs. Am Rev Respir Dis 126(6):1080–1086PubMed

15.

Ereso AQ, Ramirez RM, Sadjadi J et al (2007) Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak. J Am Coll Surg 205(4):527–533CrossRefPubMed

Titel: Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
verfasst von: Daniel E. Leisman
Clifford S. Deutschman
Matthieu Legrand
Publikationsdatum: 28.04.2020
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: Intensive Care Medicine / Ausgabe 6/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-020-06059-6

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

Sometimes more is not always better: ScvO2 monitoring in pediatric sepsis

Correction to: Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit

Tracheostomy in traumatic brain injured: solving the conundrum of the immortal time bias

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS